Share this article Share this article CHICAGO, April 20, 2021 /PRNewswire/ -- Innovative tech company Kalderos today released its 2021 annual report. The report highlights the company's perspective on key challenges in the drug channel, leverages unique data to provide insights into drug discount programs, and advocates for a new model that utilizes platform technology to make drugs more affordable for patients. "As we dive deeper into 2021, we see big developments on the horizon for the business of healthcare," said Kalderos CEO Jeremy Docken. "Industry trends are driving change and so is the massive impact of COVID-19. A new administration is tackling drug pricing. During this pivotal moment, it's the perfect time to launch our inaugural annual report."